- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Growth Potential Companies
U.S. Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Apr 01, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
170 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
JAZZ | US$118.98 | -1.5% | -18.2% | US$7.5b | US$188.79 | PE17.9x | E15.7% | n/a | ||
ANIP | US$67.87 | -2.5% | 74.8% | US$1.4b | US$79.80 | PE86.5x | E37.4% | n/a | ||
RVTY | US$103.27 | 0.3% | -21.4% | US$13.0b | US$123.11 | PE71.1x | E24.1% | 0.3% | ||
BIO | US$338.98 | -0.6% | -27.1% | US$9.8b | US$435.73 | PS3.6x | E81.3% | n/a | ||
DMAC | US$2.73 | 1.9% | 70.6% | US$105.1m | US$7.00 | PB2x | E26.8% | n/a | ||
AYTU | US$2.99 | -2.1% | 25.6% | US$16.9m | US$8.00 | PB0.5x | E96.6% | n/a | ||
GLYC | US$3.04 | 7.8% | 143.2% | US$193.4m | US$7.00 | PS19592.9x | E63.0% | n/a | ||
PBH | US$71.68 | 0.1% | 13.0% | US$3.6b | US$74.33 | PS3.1x | E34.5% | n/a | ||
ASRT | US$0.94 | -10.0% | -84.7% | US$91.1m | US$3.00 | PB0.6x | E144.9% | n/a | ||
VRTX | US$420.48 | 1.1% | 32.9% | US$108.0b | US$459.71 | PE30x | E11.2% | n/a | ||
NVAX | US$4.65 | -3.3% | -37.2% | US$669.0m | US$15.40 | PE-1.2x | E75.4% | n/a | ||
SYNH | US$42.98 | 0.6% | -8.8% | US$4.5b | US$42.63 | PE62.6x | E33.7% | n/a | ||
SYRS | US$5.04 | -21.3% | 96.9% | US$141.5m | US$19.25 | PS13.4x | E56.4% | n/a | ||
CTLT | US$56.39 | -0.02% | -10.4% | US$10.2b | US$63.50 | PS2.5x | E92.3% | n/a | ||
HBIO | US$4.26 | 3.1% | 1.7% | US$184.0m | US$7.00 | PS1.6x | E98.9% | n/a | ||
CELZ | US$5.56 | 2.6% | 11.8% | US$7.1m | US$30.00 | PS838.1x | E59.9% | n/a | ||
PFE | US$27.72 | 1.1% | -33.0% | US$157.1b | US$32.70 | PE73.6x | E20.6% | 6.1% | ||
PNT | US$12.50 | 0.2% | 75.1% | US$1.3b | US$12.50 | PE13.8x | E9.2% | n/a | ||
IMUX | US$1.36 | 4.6% | -15.5% | US$118.7m | US$6.50 | PB4.2x | E54.9% | n/a | ||
MDXG | US$7.45 | -4.9% | 123.1% | US$1.1b | US$12.44 | PE19.6x | E15.0% | n/a | ||
MRVI | US$8.60 | 1.3% | -36.6% | US$2.2b | US$9.16 | PS3.9x | E128.8% | n/a | ||
ORGO | US$2.80 | 6.9% | 30.8% | US$374.8m | US$4.83 | PE74.7x | E46.4% | n/a | ||
ATNM | US$8.56 | -1.3% | -7.0% | US$230.2m | US$25.36 | PS3106.6x | E65.0% | n/a | ||
PRGO | US$32.11 | 3.5% | -10.4% | US$4.4b | US$38.75 | PB0.9x | E47.2% | 3.4% |